Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
Zhenzhen Wang(Fujian Agriculture and Forestry University), Ke Cheng(Columbia University), Xianyun Wang(First Affiliated Hospital of Hebei Medical University), Blanca López de Juan Abad(North Carolina State University), C. Todd DeMarco(Duke University), Thomas N. Denny(Duke University), Dashuai Zhu(Columbia University Irving Medical Center), Mengrui Liu(Columbia University), Kristen D. Popowski(North Carolina State University), Phuong‐Uyen Dinh(North Carolina State University), Zhenhua Li(Key Laboratory of Guangdong Province), Nicole De Naeyer(Duke University), Halle Lutz(North Carolina State University)
Cited by 258
Related Papers
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
|Nature Communications|2020|432
Progress in brain targeting drug delivery system by nasal route
|Journal of Controlled Release|2017|389
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies
|Advanced Drug Delivery Reviews|2021|343
Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair
|Nature Communications|2021|326
microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential
|Journal of Clinical Investigation|2019|310